The major problems facing Aurora Cannabis (ACB) is that too much of the Canadian cannabis industry hasn't followed their moves with cutting cultivation capacity for 2020 and beyond. A few companies had already cut production targets for various reasons, but the bigger players in the industry still appear full speed ahead with expansion while the industry is already over supplied. For this reason, my investment thesis thinks Aurora Cannabis made smart decisions to cut production in half, but the stock isn't a buy even with the dip towards $2. A few altered production